Skip to main content

Table 3 Results of differentially expressed (foldchange and p-value) miRNAs in the validation cohort

From: MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers

MiRNA

Foldchange

p-value

hsa-miR-484

1.6

0.0026

hsa-miR-222

1.5

0.001

hsa-miR-574-3p

1.8

0.046

hsa-miR-29a

1.5

0.02

hsa-miR-195

0.6

0.0002

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us